Hinge Health and Health Catalyst Compared: Which is the Better Stock?

A look at the key differences between the two medical technology companies.

Published on Feb. 15, 2026

Got story updates? Submit your updates here. ›

Health Catalyst (NASDAQ:HCAT) and Hinge Health (NYSE:HNGE) are both medical technology companies, but which one is the better investment? The article compares the two companies across factors like net margins, revenue, earnings per share, valuation, institutional ownership, and more to determine which is the superior stock.

Why it matters

Investors looking to gain exposure to the growing medical technology sector may be weighing the merits of Health Catalyst and Hinge Health as potential investments. Understanding the key differences between the two companies can help inform investment decisions.

The details

The article provides a detailed comparison of Health Catalyst and Hinge Health across several financial and operational metrics. It highlights that Hinge Health has higher revenue and earnings than Health Catalyst, and is trading at a lower price-to-earnings ratio, indicating it may be the more affordable of the two stocks currently. The article also notes that Hinge Health has stronger institutional ownership, which can be a sign of long-term growth potential.

  • The article was published on February 15, 2026.

The players

Health Catalyst

A provider of data and analytics technology and services to healthcare organizations in the United States.

Hinge Health

A medical technology company that leverages software, including AI, to deliver automated care for joint and muscle health.

Got photos? Submit your photos here. ›

The takeaway

This comparison of Health Catalyst and Hinge Health provides investors with valuable insights to consider when evaluating the two medical technology companies as potential investment opportunities. The analysis highlights Hinge Health's potential advantages in terms of valuation and growth metrics.